|
Market Closed -
Xetra
19:35:46 30/09/2026 +04
|
After hours 23:12:42 | |||
| 373.15 EUR | +1.44% |
|
372.08 | -0.29% |
| 06:46pm | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09-28 | Scotiabank Raises Amgen Price Target to $500 From $450, Sector Outperform Rating Kept | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Amgen Inc.(AMGN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Amgen Inc.(AMGN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Amgen Inc.(AMGN)
EBIT
Dividend / Share (DPS)
Data source:
Amgen Inc.(AMGN)
Cash or Net Debt
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
- Consensus Amgen Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
